google_counter
background_img

University Hospital Carl Gustav Carus Dresden

Dresden, Germany


Department of Nuclear Medicine


Jörg Kotzerke

Prof. Dr. med.

Jörg Kotzerke

Specialized in: nuclear medicine

Curriculum vitae keyboard_arrow_down

Education

  • 1977-1983 Hannover Medical School, Germany
  • 1983 Diploma (Medicine), Hannover Medical School, Germany
  • 1985 MD with Prof. Dr. Heinz Hundeshagen, Hannover Medical School,
  • Germany (Dr. med.)
  • 1991 Venia legendi (Nuclear Medicine) and academic degree (Dr. med.
  • habil.), Hannover Medical School, Germany

Training:

  • 1984-1988 Assistant, Institute of Nuclear Medicine and Biophysics, Hannover
  • Medical School
  • 1989-1995 Senior consultant, Institute of Nuclear Medicine and Biophysics,
  • Hannover Medical School, Germany

Clinical Experience:

  • Tumour diagnosis with PET, radionuclide therapy

Professional Appointments:

  • 1995–2002 Associate Professor of Cardiovascular Nuclear Medicine, Dept. of Nuclear Medicine, University of Ulm
  • 2002-present Professor of Nuclear Medicine, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, and Medical Leader of Positron Emission Tomography Center, Research Center Dresden-Rossendorf

Societies:

  • ​DGN, DRG, EANM, SNM, DKG 
Publications keyboard_arrow_down

https://www.ncbi.nlm.nih.gov/pubmed/?term=Kotzerke+J.

The Department of Nuclear Medicine at the University Hospital Carl Gustav Carus Dresden under the direction of Prof. Dr. med. Jörg Kotzerke is distinguished due to ist high professional competence in the field of diagnosis and treatment by open radionuclides. The treatment by open radionuclides has been provided in the Department since 1970. The most common treatment form is thyroid radioiodine therapy. 

The Department under the direction of Prof. Dr. med. Jörg Kotzerke is the center for the treatment of benign and malignant thyroid diseases. With 18 beds, the Department ranks among the largest ones in Germany. Over the past two decades, the range of medical services has been significantly expanded. The interventional radionuclide therapy for neuroendocrine tumors makes up one more focus of nuclear medicine at the University Hospital Carl Gustav Carus Dresden today. For the treatment of malignant lymphomas, particular attention is also paid to radioimmunotherapy. 

In the field of diagnosis, the University Hospital Carl Gustav Carus Dresden has all modern diagnostic methods, including a gamma camera, PET/CT and PET/MRI. The most frequent examinations include scintigraphy of the thyroid, parathyroid, lungs, brain, heart and kidneys. 

In tight cooperation with other disciplines, the Department of Nuclear Medicine offers a wide range of modern diagnosis by radioactive substances:

  • Comprehensive diagnosis of tyroid and pituitary
  • Highly specialized radioisotope diagnosis of various organs, including dynamic scintigraphy (SPECT)
  • Tomography techniques PET, PET/CT, as well as PET/MRI, especially for cancer clinical pictures
  • Whole-body scintigraphy in case of skeleton diagnosis / cancer
  • Receptor scintigraphy
  • Diagnosis of inflammations and tumor diagnosis by radioimmune scintigraphy
  • Scintigraphy of lymphatic vessels (imaging of the sentinel lymph node)
  • Ultrasonic diagnosis
  • In vitro diagnosis

The range of medical services of the Department of Nuclear Medicine at the University Hospital Carl Gustav Carus Dresden includes:

  • Radioiodine therapy for benign thyroid tumors
  • Radioiodine therapy for malignant thyroid tumors
  • Receptor radiotherapy for neuroendocrine tumors
  • Radioimmune therapy for malignant lymphomas
  • Radiosynovectomy (RSO) for inflammatory joint diseases
  • Palliative pain therapy for bone metastases
  • SIRT for liver tumors / liver metastases
  • MIBG therapy 



Feedback of our customers from other resources

Need Help?

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.